Dr Graham Collins (MBBS, MRCP, FRCPath, DPhil) is a Consultant Haematologist and lymphoma lead clinician at the Oxford Cancer and Haematology Centre, and Honorary Senior Clinical Lecturer at the University of Oxford. He trained in medicine at Cambridge and Bart’s and the Royal London and then undertook haematology training in Oxford. He completed a DPhil in the molecular biology of the Reed–Sternberg cell under the late Prof David Mason and his current research interests are in early-phase trials of novel drug combinations in lymphoma, along with the development of clinically relevant biomarkers.
Dr Collins is the chair of the national Hodgkin lymphoma study group and T-cell lymphoma working group. His is local PI on over 30 lymphoma trials and national chief investigator of 4 investigator-initiated trials some recruiting and some in development. He co-authored the national guidelines for relapsed / refractory Hodgkin lymphoma and was a member of the NICE guidelines committee for the management of non-Hodgkin Lymphoma. He is course organiser for the National Lymphoma Management course and sits on the medical advisory panels of Lymphoma Action and Bloodwise. He is passionately concerned about improving outcomes of patients with lymphoma and improving their cancer journey experience